The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting to be held on June 8, 2011. The proposed agenda is as follows:
Morning Session
• Greetings, TC Update, and Overview (10:00 - 10:30 am EDT): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600
• Microsoft v. i4i Ltd.: How potential changes in the evidentiary standard for an invalidity defense could affect patent prosecution and litigation (10:30 - 11:15 am): Garth M. Dahlen, Ph.D., Esq., Birch, Stewart, Kolasch & Birch, LLP
• Break (11:15 - 11:30 am)
• COPA (Clearing the Oldest Patent Applications) (11:30 am - 12:15 pm): John Barlow, SPE, Technology Center 2800
• Expedited Examinations (Track 1, PPH, Green Tech, AE, and to Make Special) (12:00 - 1:00 pm): Bennett Celsa, QAS, Technology Center 1600
• Lunch (1:00 – 2:00 pm)
Afternoon Session
• Current Sequence Listing Process for Nucleic Acids and Polypeptides (2:00 - 2:45 pm): Joe Woitach, SPE, Art Unit 1633
• Break (2:45 - 3:00 pm)
• Common Issues Examiners Face Regarding PLTs and Plant Utility Patents (3:00 - 3:45 pm): Anne Marie Grunberg, SPE, Art Unit 1638/1661
• Closing Remarks/Discussion (3:45 - 4:00 pm): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600
The meeting can be attended in person at the USPTO's Auditorium in Madison East, 600 Dulany Street, Alexandria, VA, or viewed online here (select the "enter as guest" option). The Patent Office asks that non-USPTO employees login using their e-mail addresses. Additional information regarding the BCP customer partnership meeting can be found here.
Comments